Clinical trial
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI)…
NCT00334048 · St. Luke's-Roosevelt Hospital Center, Other · Completed
Key facts
| NCT number | NCT00334048 |
|---|---|
| Title | Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo |
| Official title | Treatment of Sexual Dysfunction Secondary to Antidepressant Pharmacotherapy: A Double-blind Comparison of Requip (Ropinirole) vs. Placebo in Patients Taking SSRI Antidepressants |
| Lead sponsor | St. Luke's-Roosevelt Hospital Center, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sexual Dysfunction |
| Intervention type | Drug |
| Interventions | Ropinirole (Requip) |
| Enrollment | 9 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 6, 2006 |
| Last update posted | Feb 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: